SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
TWD 87.0
(-0.57%)
TWD 87.0
(-0.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 393.6 Million TWD | 23.36% |
| 2022 | 319.07 Million TWD | 32.93% |
| 2021 | 240.03 Million TWD | -27.95% |
| 2020 | 333.14 Million TWD | 23.31% |
| 2019 | 270.17 Million TWD | 28.01% |
| 2018 | 211.05 Million TWD | 38.2% |
| 2017 | 152.71 Million TWD | -32.09% |
| 2016 | 224.87 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 109.35 Million TWD | 15.92% |
| 2024 Q2 | 144.27 Million TWD | 31.94% |
| 2023 FY | - TWD | 23.36% |
| 2023 Q1 | 103.76 Million TWD | 24.54% |
| 2023 Q2 | 83.78 Million TWD | -19.26% |
| 2023 Q4 | 95.14 Million TWD | -14.21% |
| 2023 Q3 | 110.91 Million TWD | 32.38% |
| 2022 Q1 | 29.4 Million TWD | 38.2% |
| 2022 Q4 | 83.32 Million TWD | -20.64% |
| 2022 Q3 | 104.99 Million TWD | 45.19% |
| 2022 Q2 | 72.31 Million TWD | 145.94% |
| 2022 FY | - TWD | 32.93% |
| 2021 Q3 | 47.72 Million TWD | 0.0% |
| 2021 FY | - TWD | -27.95% |
| 2021 Q4 | 21.27 Million TWD | -55.42% |
| 2020 FY | - TWD | 23.31% |
| 2019 FY | - TWD | 28.01% |
| 2018 FY | - TWD | 38.2% |
| 2017 FY | - TWD | -32.09% |
| 2016 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sagittarius Life Science Corp | -44.73 Million TWD | 979.781% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 645.802% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 373.917% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 479.873% |
| Visgeneer Inc. | 973 Thousand TWD | -40352.724% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 57.969% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | -294.248% |
| Neith Corporation | -33.61 Million TWD | 1271.095% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 22760.046% |
| Enimmune corporation | -228.96 Million TWD | 271.908% |
| TaiRx, Inc. | -208.64 Million TWD | 288.647% |
| EirGenix Inc. | -664.4 Million TWD | 159.242% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -432.59% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -469.262% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 447.997% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -1029.815% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 1596.597% |
| RBC Bioscience Corporation | 36.54 Million TWD | -976.983% |
| BiOptic Inc. | 65.03 Million TWD | -505.192% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 951.148% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 1292.526% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 816.753% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 9.215% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 215.942% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 139.714% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 731.374% |
| Level Biotechnology Inc. | 98.7 Million TWD | -298.773% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 1659.882% |
| GlycoNex Incorporation | -126.82 Million TWD | 410.348% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -1704.7% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 2320.495% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 136.737% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 157.674% |
| VBI | -6.97 Million TWD | 5745.511% |
| CHO Pharma, Inc. | -277.73 Million TWD | 241.722% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 591.564% |
| NaviFUS Corp. | -55.79 Million TWD | 805.449% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 2471.4% |
| Sinew Pharma Inc. | -163.63 Million TWD | 340.544% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 740.008% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | -104.574% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 273.641% |
| AP Biosciences Inc | -325.51 Million TWD | 220.918% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 137.679% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 1198.044% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -1251.202% |
| Intech Biopharm Corporation | -219.58 Million TWD | 279.249% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 158.379% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 975.631% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 344.692% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 39.955% |
| TCI GENE Inc. | 25.98 Million TWD | -1414.972% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 455.759% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 238.698% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 369.648% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -2741.913% |
| PharmaEngine, Inc. | 347.3 Million TWD | -13.331% |
| Savior Lifetec Corporation | 219.6 Million TWD | -79.233% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | -128.535% |
| OBI Pharma, Inc. | -855.08 Million TWD | 146.031% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 525.229% |
| Acepodia, Inc. | -764.51 Million TWD | 151.484% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 185.55% |